BADANIA KONTROLOWANE i CASE STUDIES

AOTI jest zaangażowana w dostarczanie najsilniejszych dowodów naukowych o skuteczności, jakości klinicznej i jakości życia pacjentów w naszej unikatowej Miejscowej Terapii Tlenem - Topical Wound Oxygen (TWO2).
Poniższa tabela podsumowuje wyczerpująco opublikowane już dowody kliniczne na temat przydatności terapii TWO2. Dodatkowo, firma jest w trakcie prowadzenia dalszych badań dla różnych rodzajów ran, w tym wieloośrodkowej, wielonarodowej, kontrolowanej z użyciem placebo, kontrolowanej losowo próby 220 pacjentów, aby dalej badać kliniczne wyniki i oszczędności w leczeniu pacjentów z ranami przewlekłymi różnego typu i etiologii.

 

POBIERZ

 

 

Author

Journal

Study Type

No. of Patients

Ulcer
Type

Outcome

Tawfick, W et al

Vascular and Endovascular Surgery

Controlled
Cohort Study

132

Venous

Mean reduction in ulcer surface area at 12 weeks was 96% with 76% of ulcers
completely healed
Median time to full healing was 57 days
6% ulcer reoccurrence after 36 months follow-up

Blackman E et al

Ostomy Wound Management

Prospective Controlled Study

28

Diabetic

82.4% of ulcers completely healed at 12 weeks
Median time to full healing was 56 days
No ulcer reoccurrence after 24 months follow-up

Ichioka S et al

Wounds International

Case Series

6

Pressure & Diabetic

Improved ulcer healing
Increased the oxygen values of peri-wound area

Aburto et al

Journal of Wound
Technology

Randomized Controlled Trial

40

Diabetic & Venous

Diabetic ulcers 90% healing in 12 weeks
Venous ulcers 50% healed in 12 weeks

Sultan S et al

European Journal of Vascular and Endovascular Surgery

Parallel study

83

Venous

80% ulcers healed at 12 weeks
Median time to full healing was 45 days
No ulcer reoccurrence after 12 months follow-up Pain score improved from 8 to 3 by day 13

Japour C et al

Desert Foot Conference Proceedings

Case Series

5

Diabetic

Average time to 100% closure was 3.4 months
Average number of treatments to closure was 45

Derk F et al

Desert Foot Conference Proceedings

Case Series

9

Diabetic & Dehiscence

Average time to 100% closure was 12.7 weeks

Levine B et al

Desert Foot Conference Proceedings

Case Series

14

Diabetic & Venous

Average time to 100% closure was 11.5 weeks
Average number of treatments to closure was 33

Kallianen LK et al

Pathophysiology

Case series

32

Mixed

75% closure rate. No side effects

Edsberg LE et al

Ostomy and Wound Management

Randomized Controlled Trial

8

Pressure

Healing of all wounds

Landau Z et al

Yale Journal Biology & Medicine

Prospective open study

100

Diabetic

81% Healing

Heng MC et al

Ostomy and Wound Management

Prospective Randomized study

40

Pressure

90% closure rate

Heng MC et al

Ostomy and Wound Management

Prospective Study

15

Pressure

Overall improvement in ulcer size over time

Landau Z et al

Arch Orthopedic Trauma Surgery

Prospective study

50

Diabetic

86% closure rate

Heng MC et al

American Journal Dermatopatho.

Case series

6

Pressure

Some clinical improvement

Ignacio DR et al

Journal American Podiatry Asso.

Case series

15

Mixed

73% healing rate

Heng MC et al

Archives Dermatology

Prospective non- randomized study

6

Necrotic Pressure

100% healing in TOT group

Diamond E et al

Journal American Podiatry Assoc

Case series

11

Mixed

100% healing

Olejniezak S

Medical Times

Meta-Analysis Self Control

174

Mixed

Very Effective/ Favorable Results

Fischer BH

Journal Dermatological Surgery

Case series

30

Mixed

Overall positive results

Fischer BH

Lancet

Case series

52

Mixed

Positive results

'